X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209532
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209792
https://www.biospace.com/article/releases/daiichi-sankyo-announces-late-breaking-phase-1-dose-expansion-data-for-patritumab-deruxtecan-in-patients-with-egfr-mutated-nsclc-at-esmo-2020/?s=73
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212827
http://www.pmlive.com/pharma_news/j_and_js_bispecific_lung_cancer_antibody_nabs_fda_breakthrough_status_1328830
http://www.pmlive.com/pharma_news/tagrisso_tops_rival_drugs_on_survival_in_first-line_lung_cancer_1296900
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211826
https://www.fiercepharma.com/pharma/nice-shuts-down-az-s-tagrisso-and-backs-pfizer-rival-vizimpro-instead?utm_source=internal&utm_medium=rss
http://www.pharmatimes.com/news/nice_ok_for_life-extending_vizimpro_in_lung_cancer_1293312
https://www.raps.org/news-and-articles/news-articles/2018/12/fda-drafts-guidance-on-oncology-companion-diagnost?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%207%20December
https://www.ema.europa.eu/documents/product-information/gefitinib-mylan-epar-product-information_en.pdf
https://seekingalpha.com/article/4202077-chinas-pharma-boom
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/07/news_detail_002994.jsp&mid=WC0b01ac058004d5c1
https://www.fiercepharma.com/pharma-asia/china-speeds-cancer-drug-price-cuts-as-movie-smuggled-indian-generics-causes-a-stir
https://www.fiercebiotech.com/biotech/asco-pfizer-s-dacomitinib-bests-iressa-nsclc-overall-survival-showdown
http://www.pharmatimes.com/news/pfizer_files_lung_cancer_drug_in_the_eu,_us_1230459
http://www.pmlive.com/pharma_news/clock_starts_ticking_on_azs_first-line_lung_cancer_filing_in_us_1214772
http://www.pharmatimes.com/news/us_priority_review_for_az_tagrisso_1214692
http://www.reuters.com/article/us-health-cancer-pfizer-idUSKBN18W1HD
http://www.fiercebiotech.com/biotech/asco-chi-med-s-fruquintinib-a-safer-colorectal-cancer-med-combo-therapies-sight
http://www.nasdaq.com/article/astellas-pharma-to-discontinue-asp8273-treatment-arm-in-latestage-solar-trial-20170510-01889
https://www.bloomberg.com/news/articles/2017-02-23/china-expands-drug-insurance-coverage-in-boost-to-pharma-stocks
http://www.pmlive.com/pharma_news/generic_version_of_azs_iressa_launched_in_china_1187233
http://www.pharmafile.com/news/513360/generic-version-top-selling-lung-cancer-drug-hits-chinese-market
http://www.reuters.com/article/us-astrazeneca-cancer-pill-idUSKBN13V0VH
http://www.fiercepharma.com/pharma/gsk-expects-deep-discount-for-viread-china-to-boost-sales
http://www.fiercepharma.com/pharma-asia/astrazeneca-keeps-double-digit-china-growth-track-q1
http://www.biospectrumasia.com/biospectrum/analysis/223532/asias-burden-lung-cancer/page/2
http://www.fiercepharmaasia.com/story/az-approval-tagrisso-japan-big-change-nsclc-treatment-options-asia/2016-03-29
http://www.fiercepharmaasia.com/story/china-nhfpc-drug-price-pilot-signals-volume-cost-cuts-formula/2016-03-12
http://www.biospectrumindia.com/biospecindia/news/223413/boehringer-s-gilotrif-gain-ground-nsclc-markets-outside-usa
http://www.prnewswire.com/news-releases/roche-receives-approval-in-japan-for-the-cobas-egfr-mutation-test-v2-300233670.html
http://www.prnewswire.com/news-releases/boehringer-ingelheims-gilotrif-afatinib-demonstrated-superiority-to-iressa-gefitinib-in-reducing-the-risk-of-disease-progression-and-treatment-failure-in-first-line-treatment-of-patients-with-egfr-mutation-positive-advanced-300210373.html
http://www.pharmatimes.com/Article/15-12-21/93_medicines_recommended_by_CHMP_in_2015.aspx
http://www.pmlive.com/pharma_news/uk_patients_get_early_access_to_azs_lung_cancer_drug_tagrisso_883737
http://www.pharmatimes.com/Article/15-12-08/Five_medicines_cleared_for_use_by_NHS_Scotland.aspx?
http://www.prnewswire.com/news-releases/diplomat-to-dispense-astrazeneca-drug-iressa-300126407.html
http://www.reuters.com/article/us-china-pharmaceuticals-idUSKCN0YB183
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30
http://www.astrazeneca.com/Media/Press-releases/Article/20150414--tremelimumab-granted-orphan-drug-designation-by-us-fda
http://www.qiagen.com/in/about-us/press-releases/pressreleaseview?ID={6B89806C-A9D7-4944-BC13-C227089F0DAB}&lang=en
Market Place
Share 
